223 related articles for article (PubMed ID: 16647256)
1. Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors.
Bondebjerg J; Fuglsang H; Valeur KR; Pedersen J; Naerum L
Bioorg Med Chem Lett; 2006 Jul; 16(13):3614-7. PubMed ID: 16647256
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C.
Guay D; Beaulieu C; Truchon JF; Jagadeeswar Reddy T; Zamboni R; Bayly CI; Methot N; Rubin J; Ethier D; David Percival M
Bioorg Med Chem Lett; 2009 Sep; 19(18):5392-6. PubMed ID: 19665376
[TBL] [Abstract][Full Text] [Related]
3. Dipeptide nitrile inhibitors of cathepsin K.
Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Lattmann R; Missbach M
Bioorg Med Chem Lett; 2006 May; 16(9):2549-54. PubMed ID: 16480867
[TBL] [Abstract][Full Text] [Related]
4. Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1.
Magnin DR; Taunk PC; Robertson JG; Wang A; Marcinkeviciene J; Kirby MS; Hamann LG
Bioorg Med Chem Lett; 2006 Mar; 16(6):1731-4. PubMed ID: 16376077
[TBL] [Abstract][Full Text] [Related]
5. Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors.
Simpkins LM; Bolton S; Pi Z; Sutton JC; Kwon C; Zhao G; Magnin DR; Augeri DJ; Gungor T; Rotella DP; Sun Z; Liu Y; Slusarchyk WS; Marcinkeviciene J; Robertson JG; Wang A; Robl JA; Atwal KS; Zahler RL; Parker RA; Kirby MS; Hamann LG
Bioorg Med Chem Lett; 2007 Dec; 17(23):6476-80. PubMed ID: 17937986
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of dipeptide nitriles as reversible and potent Cathepsin S inhibitors.
Ward YD; Thomson DS; Frye LL; Cywin CL; Morwick T; Emmanuel MJ; Zindell R; McNeil D; Bekkali Y; Girardot M; Hrapchak M; DeTuri M; Crane K; White D; Pav S; Wang Y; Hao MH; Grygon CA; Labadia ME; Freeman DM; Davidson W; Hopkins JL; Brown ML; Spero DM
J Med Chem; 2002 Dec; 45(25):5471-82. PubMed ID: 12459015
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.
Van der Veken P; De Meester I; Dubois V; Soroka A; Van Goethem S; Maes MB; Brandt I; Lambeir AM; Chen X; Haemers A; Scharpé S; Augustyns K
Bioorg Med Chem Lett; 2008 Jul; 18(14):4154-8. PubMed ID: 18556199
[TBL] [Abstract][Full Text] [Related]
8. New cathepsin inhibitors to explore the fluorophilic properties of the S2 pocket of cathepsin B: design, synthesis, and biological evaluation.
Fustero S; Rodrigo V; Sánchez-Roselló M; del Pozo C; Timoneda J; Frizler M; Sisay MT; Bajorath J; Calle LP; Cañada FJ; Jiménez-Barbero J; Gütschow M
Chemistry; 2011 May; 17(19):5256-60. PubMed ID: 21452179
[No Abstract] [Full Text] [Related]
9. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
Löser R; Gütschow M
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.
Van Goethem S; Van der Veken P; Dubois V; Soroka A; Lambeir AM; Chen X; Haemers A; Scharpé S; De Meester I; Augustyns K
Bioorg Med Chem Lett; 2008 Jul; 18(14):4159-62. PubMed ID: 18556198
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors.
Magnin DR; Robl JA; Sulsky RB; Augeri DJ; Huang Y; Simpkins LM; Taunk PC; Betebenner DA; Robertson JG; Abboa-Offei BE; Wang A; Cap M; Xin L; Tao L; Sitkoff DF; Malley MF; Gougoutas JZ; Khanna A; Huang Q; Han SP; Parker RA; Hamann LG
J Med Chem; 2004 May; 47(10):2587-98. PubMed ID: 15115400
[TBL] [Abstract][Full Text] [Related]
12. Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays.
Ren XF; Li HW; Fang X; Wu Y; Wang L; Zou S
Org Biomol Chem; 2013 Feb; 11(7):1143-8. PubMed ID: 23299878
[TBL] [Abstract][Full Text] [Related]
13. Facing the gem-dialkyl effect in enzyme inhibitor design: preparation of homocycloleucine-based azadipeptide nitriles.
Frizler M; Lohr F; Lülsdorff M; Gütschow M
Chemistry; 2011 Oct; 17(41):11419-23. PubMed ID: 21898616
[No Abstract] [Full Text] [Related]
14. Aminoacylpyrrolidine-2-nitriles: potent and stable inhibitors of dipeptidyl-peptidase IV (CD 26).
Li J; Wilk E; Wilk S
Arch Biochem Biophys; 1995 Oct; 323(1):148-54. PubMed ID: 7487060
[TBL] [Abstract][Full Text] [Related]
15. Bicyclic cyanothiazolidines as novel dipeptidyl peptidase 4 inhibitors.
Betancort JM; Winn DT; Liu R; Xu Q; Liu J; Liao W; Chen SH; Carney D; Hanway D; Schmeits J; Li X; Gordon E; Campbell DA
Bioorg Med Chem Lett; 2009 Aug; 19(15):4437-40. PubMed ID: 19482472
[TBL] [Abstract][Full Text] [Related]
16. Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design.
Greenspan PD; Clark KL; Tommasi RA; Cowen SD; McQuire LW; Farley DL; van Duzer JH; Goldberg RL; Zhou H; Du Z; Fitt JJ; Coppa DE; Fang Z; Macchia W; Zhu L; Capparelli MP; Goldstein R; Wigg AM; Doughty JR; Bohacek RS; Knap AK
J Med Chem; 2001 Dec; 44(26):4524-34. PubMed ID: 11741472
[TBL] [Abstract][Full Text] [Related]
17. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
Löser R; Schilling K; Dimmig E; Gütschow M
J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
[TBL] [Abstract][Full Text] [Related]
18. Structural optimization of azadipeptide nitriles strongly increases association rates and allows the development of selective cathepsin inhibitors.
Frizler M; Lohr F; Furtmann N; Kläs J; Gütschow M
J Med Chem; 2011 Jan; 54(1):396-400. PubMed ID: 21128614
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C).
Kam CM; Götz MG; Koot G; McGuire M; Thiele D; Hudig D; Powers JC
Arch Biochem Biophys; 2004 Jul; 427(2):123-34. PubMed ID: 15196986
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
